Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Midatech Pharma US Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Midatech Pharma US Inc. | d285235d10k.htm |
| EX-21 - SUBSIDIARIES OF DARA BIOSCIENCES, INC. - Midatech Pharma US Inc. | d285235dex21.htm |
| EX-32 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - Midatech Pharma US Inc. | d285235dex32.htm |
| EX-31.1 - CERTIFICATION PURSUANT TO SECTION 302 - Midatech Pharma US Inc. | d285235dex311.htm |
| EX-31.2 - CERTIFICATION PURSUANT TO SECTION 302 - Midatech Pharma US Inc. | d285235dex312.htm |
| EX-10.25 - CHANGE IN CONTROL AGREEMENT - Midatech Pharma US Inc. | d285235dex1025.htm |
Exhibit 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| (1) |
Registration Statement (Form S-8 No. 333-150129) pertaining to the DARA Biosciences, Inc. 2003 Amended and Restated Employee, Director and Consultant Stock Plan and the DARA Biosciences, Inc. 2008 Employee, Director and Consultant Stock Plan of DARA BioSciences, Inc., |
| (2) |
Registration Statement (Form S-3 No. 333-150150) of DARA BioSciences, Inc., |
| (3) |
Registration Statement (Form S-1 No. 333-165884) of DARA BioSciences, Inc., and |
| (4) |
Registration Statement (Form S-1 No. 333-171449) of DARA BioSciences, Inc.; |
of our report dated February 17, 2012, with respect to the consolidated financial statements of DARA BioSciences, Inc. and subsidiaries included in this Annual Report (Form 10-K) of DARA BioSciences, Inc. and subsidiaries for the year ended December 31, 2011.
/s/ Ernst & Young LLP
Raleigh, North Carolina
February 17, 2012